Cargando…

Peptide-Based HDL as an Effective Delivery System for Lipophilic Drugs to Restrain Atherosclerosis Development

PURPOSE: Peptide-based high-density lipoprotein (pHDL) structurally and functionally resembles the natural HDL as anti-atherosclerosis (AS) therapies. Since pHDL contains a large hydrophobic core, this study aims to evaluate the potentials of pHDL as a hydrophobic drug carrier and the efficiency of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Junwei, Li, Ziyun, Li, Jing, Song, Ping, Yang, Jinsheng, Xiao, Wei, Li, Ning, Xu, Ruodan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464027/ https://www.ncbi.nlm.nih.gov/pubmed/36097444 http://dx.doi.org/10.2147/IJN.S374736

Ejemplares similares

Transdermal Delivery of Therapeutic Compounds With Nanotechnological Approaches in Psoriasis
por: Li, Ning, et al.
Publicado: (2022)

Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides
por: Daralnakhla, Haneen, et al.
Publicado: (2021)

HDL-bound sphingosine 1-phosphate restrains lymphopoiesis and neuroinflammation
por: Blaho, Victoria A., et al.
Publicado: (2015)

Broad Anti-Viral Capacities of Lian-Hua-Qing-Wen Capsule and Jin-Hua-Qing-Gan Granule and Rational use Against COVID-19 Based on Literature Mining
por: Shi, Mingfei, et al.
Publicado: (2021)

Application of Functional Biocompatible Nanomaterials to Improve Curcumin Bioavailability
por: Li, Ziyun, et al.
Publicado: (2020)

HDL, Atherosclerosis, and Emerging Therapies
por: Hafiane, Anouar, et al.
Publicado: (2013)

Enhancement of Skin Delivery of Drugs Using Proposome Depends on Drug Lipophilicity
por: Kathuria, Himanshu, et al.
Publicado: (2021)

The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
por: Chernick, Dustin, et al.
Publicado: (2020)

Development of a Novel Lipophilic, Magnetic Nanoparticle for in Vivo Drug Delivery
por: Linemann, Thomas, et al.
Publicado: (2013)

Nanoemulsion as a Platform for Iontophoretic Delivery of Lipophilic Drugs in Skin Tumors
por: Dalmolin, Luciana Facco, et al.
Publicado: (2018)

Lipomics: A Potential Carrier for the Intravenous Delivery of Lipophilic and Hydrophilic Drugs
por: Ramírez-Hernández, David, et al.
Publicado: (2022)

Scavenger Receptor BI Induced by HDL From Coronary Heart Disease May Be Related to Atherosclerosis
por: Gao, Fen, et al.
Publicado: (2021)

Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system
por: Lee, Jong Bong, et al.
Publicado: (2018)

HDL as a drug and nucleic acid delivery vehicle
por: Lacko, Andras G., et al.
Publicado: (2015)

Nanoemulsion‐Loaded Capsules for Controlled Delivery of Lipophilic Active Ingredients
por: Chen, Liang‐Hsun, et al.
Publicado: (2020)

Lung Surfactant Microbubbles Increase Lipophilic Drug Payload for Ultrasound-Targeted Delivery
por: Sirsi, Shashank R., et al.
Publicado: (2013)

HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis
por: Di Bartolo, Belinda A., et al.
Publicado: (2021)

Kaempferol inhibits SARS-CoV-2 invasion by impairing heptad repeats-mediated viral fusion
por: Gao, Junwei, et al.
Publicado: (2023)

Ethanol as a switch to induce soybean lipophilic protein self-assembly and resveratrol delivery
por: Zhong, Mingming, et al.
Publicado: (2023)

Bioengineered Vaults: Self-Assembling Protein Shell–Lipophilic Core Nanoparticles for Drug Delivery
por: Buehler, Daniel C., et al.
Publicado: (2014)

Thiol-ene Reaction: An Efficient Tool to Design Lipophilic Polyphosphoesters for Drug Delivery Systems
por: Vanslambrouck, Stéphanie, et al.
Publicado: (2021)

Effect of Lipophilic Chains on the Antitumor Effect of a Dendritic Nano Drug Delivery System
por: Ding, Lijuan, et al.
Publicado: (2022)

Recent Progress of Lipid Nanoparticles-Based Lipophilic Drug Delivery: Focus on Surface Modifications
por: Seo, Yoseph, et al.
Publicado: (2023)

Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
por: Valanti, Eftaxia-Konstantina, et al.
Publicado: (2018)

Mechanism of transdermal permeation promotion of lipophilic drugs by ethosomes
por: Yang, Li, et al.
Publicado: (2017)

Amphiphilic Iodine(III) Reagents for the Lipophilization of Peptides in Water
por: Mishra, Abhaya Kumar, et al.
Publicado: (2021)

HJ11 decoction restrains development of myocardial ischemia-reperfusion injury in rats by suppressing ACSL4-mediated ferroptosis
por: Zhang, Fangyuan, et al.
Publicado: (2022)

Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System
por: Xu, Ruodan, et al.
Publicado: (2020)

Corrigendum: Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System
por: Xu, Ruodan, et al.
Publicado: (2020)

HDL signaling and protection against coronary artery atherosclerosis in mice
por: Trigatti, Bernardo L, et al.
Publicado: (2016)

HDLs extract lipophilic drugs from cells
por: Zheng, Adi, et al.
Publicado: (2022)

Acid-base and lipophilic properties of peptide nucleic acid derivatives
por: Thakare, Pramod, et al.
Publicado: (2021)

A story of peptides, lipophilicity and chromatography – back and forth in time
por: Erckes, Vanessa, et al.
Publicado: (2022)

Association of Prolonged Disease Duration and TG/HDL-C Ratio in Accelerating Atherosclerosis in Patients with Takayasu's Arteritis
por: Du, Juan, et al.
Publicado: (2022)

Terpenes: Effect of lipophilicity in enhancing transdermal delivery of alfuzosin hydrochloride
por: Prasanthi, D., et al.
Publicado: (2012)

Nanoemulsion-Based Delivery Systems to Improve Functionality of Lipophilic Components
por: Odriozola-Serrano, Isabel, et al.
Publicado: (2014)

Lipophilic Polyamines as Promising Components of Liposomal Gene Delivery Systems
por: Puchkov, Pavel A., et al.
Publicado: (2021)

Bovine HDL and Dual Domain HDL-Mimetic Peptides Inhibit Tumor Development in Mice
por: Su, Feng, et al.
Publicado: (2020)

Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
por: Raut, Sangram, et al.
Publicado: (2018)

Roles of the Metabolic Syndrome, HDL Cholesterol, and Coronary Atherosclerosis in Subclinical Inflammation
por: Rein, Philipp, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_j4ub98gkctfmgsg3qti7096gv3